Veralox Therapeutics: Funding, Investors & Team (Oct 2026)
Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients.
Veralox Therapeutics has raised $40.6M across 2 funding rounds on record, the most recent an undisclosed round of $24.0M announced in Jun 2023.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Veralox Therapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2023.
Veralox Therapeutics Funding Rounds
Veralox Therapeutics raised $16.6M in an undisclosed round announced in Jun 2021.
2 years later, an undisclosed round of $24.0M was announced in Jun 2023.
Veralox Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Veralox Therapeutics Funding Compared to Other Biotechnology Startups
Veralox Therapeutics' latest round of $24.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Veralox Therapeutics in Biotechnology and Frederick
Companies Similar to Veralox Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Veralox Therapeutics Funding FAQs
What does Veralox Therapeutics do?
Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients.
How much funding has Veralox Therapeutics raised?
Veralox Therapeutics has raised $40.6M across 2 rounds on record. The most recent is an undisclosed round of $24.0M announced in Jun 2023.
When did Veralox Therapeutics last raise funding?
Veralox Therapeutics' most recent funding round on record is an undisclosed round of $24.0M, announced in Jun 2023.
Who founded Veralox Therapeutics?
FundedIQ lists David J Maloney (Founder) at Veralox Therapeutics.
Who is the CEO of Veralox Therapeutics?
Jeffrey Strovel is listed as CEO at Veralox Therapeutics.
Where is Veralox Therapeutics headquartered?
Veralox Therapeutics is based in Frederick, Maryland, United States.
How many employees does Veralox Therapeutics have?
Veralox Therapeutics is in the 1-10 employee band.
How does Veralox Therapeutics' funding compare to other Biotechnology startups?
Veralox Therapeutics' latest round of $24.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Veralox Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Veralox Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.